In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
All content for The Scalpel's Edge is the property of Dr. Tim Sayed and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes listeners inside the world of personalized genetic testing and how it can transform perioperative planning for explant patients and anyone seeking deeper insight into their inflammatory health. Dr. Sayed breaks down the SHARP program’s integrated approach, which combines genomic testing, supplements, psychological support, and lifestyle guidance to help patients understand their unique risks, strengths, and metabolic tendencies. Using...
Explore the growing movement of breast implant removal as Dr. Tim Sayed breaks down why twenty four well known celebrities decided to explant. In this powerful episode of The Scalpel’s Edge, Dr. Sayed explains the emotional, physical, and aesthetic reasons behind their decisions and highlights the rising awareness around breast implant illness, autoimmune symptoms, and personal identity. He also shares insights from his double board certified surgical practice, where he focuses on explant sur...
A new era of weight management is on the horizon. In this episode of The Scalpel’s Edge, learn how oral GLP-1 medications like semaglutide (Rebelsus) are changing the landscape of obesity care and cardiovascular health. Explore key findings from the OASIS-4 Phase 3 trial, new FDA updates, and what the data reveals about blood sugar control, heart health, and weight reduction across all age groups. Discover why oral options may soon rival injectables like Ozempic, Wegovy, and Mounjaro—and what...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months of follow-up, this research reveals significant improvements in symptoms such as joint pain, fatigue, and hair loss — and offers valuable insight into the science, skepticism, and evolving understanding of BII. Dr. Sayed breaks down the data, discusses parallels with U.S. studi...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed breaks down a recent CNN feature on the growing movement around explant surgery and breast implant illness. From celebrity testimonials like Alyssa Milano’s to the troubling stories of patients who felt pressured by surgeons, Dr. Sayed dives deep into what’s driving the rise in breast implant removals. He explores the science, the stigma, and the shifting mindset around body image, empowerment, and patient choice. Together, we examine how t...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the shifting regulatory landscape for compounded GLP1 medications and what recent FDA warning letters mean for providers, pharmacies, and patients. He also reviews promising new clinical trial data on Pfizer’s experimental drug MET97, which may offer greater weight loss with fewer side effects compared to current options. From the nuances of verbiage in compounding claims to the future of monthly dosing and oral formu...
On this episode of The Scalpel’s Edge we explore a fascinating new study showing how GLP1 medications like semaglutide and tirzepatide may not only improve heart failure outcomes but also reduce greenhouse gas emissions. As I break down this meta-analysis presented at the European Society of Cardiology Congress you will hear how these drugs can deliver benefits for individual patients while also contributing to global sustainability efforts. Small improvements at the patient level may add up ...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed examines one of the most debated topics in plastic surgery, breast implant illness. He reviews findings from a arecent cohort study published in Cureus while also drawing from his experience as a double board certified plastic surgeon. The discussion explores patient outcomes after explant surgery, the role of inflammation, and the balance between correlation and causation. Dr. Sayed provides historical context, addresses ongoing controvers...
On this episode of The Scalpel’s Edge, I’m diving into a fascinating new study that compares GLP-1 drugs like tirzepatide to traditional testosterone replacement therapy in men with obesity and low testosterone function. The results? Pretty eye-opening. We’ll break down how these medications - originally developed for weight loss and diabetes - are now showing promise in naturally improving testosterone levels by reactivating your body’s own hormone pathways, rather than just patching things ...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed breaks down compelling new research on GLP1 medications like semaglutide, tirzepatide, and the latest entrant, ecnoglutide. With real-world data from Cleveland Clinic and insights from an international Phase 3 trial, Dr. Sayed explores how these medications are performing outside of clinical trials, what happens after patients stop taking them, and why cost, side effects, and genetic profiles may impact their effectiveness. As a board...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed shares an inside look at a new chapter in his practice. The SHARP Program, also known as the Strategic Holistic Accelerated Recovery Program, was developed by Dr. Robert Whitfield to support explant patients through personalized wellness and recovery. Dr. Sayed walks through the details of his own participation in the program, breaking down the lab kits, testing protocols, and insights they provide. He covers everything from urine metabolit...
In this solo episode, Dr. Tim Sayed takes listeners behind the scalpel to explore a topic that’s both controversial and critical: breast implant illness (BII). With honesty and compassion, he unpacks the common symptoms that may indicate a deeper issue—from chronic fatigue and joint pain to unexplained anxiety—and how continuous exposure to implants may trigger systemic inflammation in the body. He also shares practical, evidence-informed advice on how to vet surgeons, where to find support g...
What if science could validate what thousands of women have already reported? In this episode of The Scalpel’s Edge, Dr. Tim Sayed unpacks a newly published study in Nature Portfolio that may mark a turning point in how we understand breast implant illness (BII). The study reveals a statistically significant spike in FGF-19—a critical metabolic and healing biomarker—after explant surgery, reinforcing what many in the BII community have experienced firsthand. But is this just a side effect of ...
In this powerful episode of The Scalpel’s Edge, Dr. Tim Sayed, a double board-certified plastic surgeon and holistic wellness expert, dives deep into the intersection of science, spirituality, and self-discipline. Using his own experience with Ramadan fasting as a lens, Dr. Sayed unpacks the compelling health benefits of intermittent fasting — from fat loss and improved metabolic markers to enhanced emotional well-being and even athletic performance. But this isn't just another episode on die...
What if your post-surgery recovery isn’t just about the incision—it's about your entire body reclaiming balance? On this powerful episode of The Scalpel's Edge, Dr. Tim Sayed sits down with lymphatic massage expert Kathleen Lisson to expose the overlooked truths about surgical healing, breast implant illness, and the silent role of the lymphatic system. From cupping therapy to stress balls and even blowing bubbles (yes, really), they explore how science, self-care, and scar massage can transf...
Could your recovery from breast implant illness be dramatically improved—just by supporting one overlooked system in your body? Dr. Tim Sayed teams up with expert lymphatic therapist Kathleen Lisson to reveal how manual lymphatic drainage (MLD) is transforming explant healing. From swelling relief to scar care, and even emotional release, this episode uncovers what most plastic surgeons aren’t talking about. You’ll learn why movement, breathwork, and even your grandma’s soup recipe could hold...
In this eye-opening episode of The Scalpel’s Edge, double board-certified plastic surgeon Dr. Tim Sayed pulls back the curtain on the dark side of GLP-1 drugs like Ozempic and semaglutide. While these medications are hailed for their dramatic weight loss results, Dr. Sayed explores the less-discussed truth—up to 40% of that weight loss may actually be muscle mass. He dives into the science behind this phenomenon, the rising role of peptides like ipamorelin, and biotech innovations like myosta...
In this transformative episode of The Scalpel’s Edge, Dr. Tim Sayed—double board-certified plastic surgeon and holistic health advocate—dives deep into the cutting-edge world of GLP-1 medications like Ozempic, Wegovy, and Mounjaro. With 40 pounds of personal weight loss under his belt, Dr. Syed shares what really works, what to watch out for, and why this is far more than just another diet trend. He breaks down how these meds are changing lives, not just by shrinking waistlines, but by curbin...
Dr. Tim Sayed isn’t your typical plastic surgeon. In this transformative episode of The Scalpel’s Edge, he explores why true healing goes far beyond the operating room. From breast implant illness and functional medicine to leadership lessons from Brown University, Dr. Sayed shares how strategy, culture, and compassion intersect to create real, lasting health. Get ready for a behind-the-scenes look at how one doctor is rethinking everything—from patient trust to goal-setting, weight loss, and...
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
